Related references
Note: Only part of the references are listed.Therapeutic advantage of angiotensin-converting enzyme inhibitors in patients with proteinuric chronic kidney disease
Kiyotsugu Omae et al.
HEART AND VESSELS (2010)
Risk of Hyperkalemia in Nondiabetic Patients With Chronic Kidney Disease Receiving Antihypertensive Therapy
Joy M. Weinberg et al.
ARCHIVES OF INTERNAL MEDICINE (2009)
Prescription of antihypertensive agents to haemodialysis patients: time trends and associations with patient characteristics, country and survival in the DOPPS
Antonio Alberto Lopes et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2009)
Blood pressure, antihypertensive treatment, and graft survival in kidney transplant patients
Uta Hillebrand et al.
TRANSPLANT INTERNATIONAL (2009)
The effects of amlodipine and enalapril on renal function in adults with hypertension and nondiabetic nephropathies: A 3-year, randomized, multicenter, double-blind, placebo-controlled study
Vincent L. M. Esnault et al.
CLINICAL THERAPEUTICS (2008)
Determinants of new-onset diabetes among 19,257 hypertensive patients randomized in the Anglo-Scandinavian Cardiac Outcomes Trial-blood pressure lowering arm and the relative influence of antihypertensive medication
Ajay K. Gupta et al.
DIABETES CARE (2008)
ACE inhibitor reduces growth factor receptor expression and signaling but also albuminuria through B2-kinin glomerular receptor activation in diabetic rats
Julien Allard et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2007)
Predictors of survival after cardiac arrest in outpatient hemodialysis clinics
Patrick H. Pun et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2007)
Calcium channels blockers and progression of kidney disease
Stavroula Ziakka et al.
RENAL FAILURE (2007)
Outcomes in hypertensive black and nonblack patients treated with chlorthalidone, amlodipine, and lisinopril
JT Wright et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2005)
Angiotensin-converting-enzyme inhibitors slow renal decline in IgA nephropathy, independent of tubulointerstitial fibrosis at presentation
Y Kanno et al.
QJM-AN INTERNATIONAL JOURNAL OF MEDICINE (2005)
Excerpts from the United States Renal Data System 2004 Annual Data Report: Atlas of end-stage renal disease in the United States - Perface
AJ Collins et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2005)
The metabolic syndrome and chronic kidney disease in US adults
J Chen et al.
ANNALS OF INTERNAL MEDICINE (2004)
Bradykinin decreases plasminogen activator inhibitor-1 expression and facilitates matrix degradation in the renal tubulointerstitium under angiotensin-converting enzyme blockade
H Okada et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2004)
Differential effects of calcium antagonist subclasses on markers of nephropathy progression
GL Bakris et al.
KIDNEY INTERNATIONAL (2004)
Direct comparison of the effects of valsartan and amlodipine on renal hemodynamics in human essential hypertension
C Delles et al.
AMERICAN JOURNAL OF HYPERTENSION (2003)
Measuring inconsistency in meta-analyses
JPT Higgins et al.
BMJ-BRITISH MEDICAL JOURNAL (2003)
Blood pressure predicts risk of developing end-stage renal disease in men and women
M Tozawa et al.
HYPERTENSION (2003)
Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease - Results from the AASK trial
JT Wright et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2002)
Renal function: The Cinderella of cardiovascular risk profile
LM Ruilope et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2001)
A random comparison of fosinopril and nifedipine GITS in patients with primary renal disease
R Marin et al.
JOURNAL OF HYPERTENSION (2001)
Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes
EJ Lewis et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
ACE inhibition or angiotensin receptor blockade: Impact on potassium in renal failure
GL Bakris et al.
KIDNEY INTERNATIONAL (2000)
Share Paper
